Man­u­fac­tur­ing roundup: Hik­ma, Lil­ly US man­u­fac­tur­ing sites hit with 483s; GAO says HHS should ad­dress stock­pile risks

The FDA has hand­ed down in­spec­tion re­ports to sev­er­al man­u­fac­tur­ing sites in New Jer­sey, re­veal­ing a range of qual­i­ty con­trol is­sues.

The 483 in­spec­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER